Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies
Leslie Citrome,1 Judith C Kando,2 Caleb Bliss3 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Shire, Global Medical Affairs, Lexington, MA, USA; 3Shire, Biostatistics, Lexington, MA, USA Objectives: In two Phase III studies, lisdexamfetamine dimesy...
Guardado en:
Autores principales: | Citrome L, Kando JC, Bliss C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9326646c9c940f0a231e13815458866 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova AI, et al.
Publicado: (2016) -
Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges
por: Chevinsky JD, et al.
Publicado: (2020) -
Impact of Bariatric Surgery on the Healthy Eating Index, Binge Eating Behavior and Food Craving in a Middle Eastern Population: A Lebanese Experience
por: Jana Jabbour, et al.
Publicado: (2021) -
Compulsive Eating in a Rat Model of Binge Eating Disorder Under Conditioned Fear and Exploration of Neural Mechanisms With c-fos mRNA Expression
por: Zhi Fei Li, et al.
Publicado: (2021) -
Prevalence of Binge-Eating Disorder and Its Association with Nicotine Dependence Among Under-Graduate Students at a Saudi Public University
por: Bin Abdulrahman KA, et al.
Publicado: (2021)